Skip to content
Founder & CEO of Empiriko
Senior Partner, Technology Companies & Life Sciences Group at Goodwin
Chairman and CEO of Xontogeny
Immediate Past Chair
Co-founder, President and Chief Executive Officer of Frequency Therapeutics
Partner at Third Rock Ventures
SVP, General Counsel and Secretary of Alnylam Pharmaceuticals, Inc.
Chief Executive Officer of MilliporeSigma
President & CEO of Anika Therapeutics, Inc.
CEO, Mayfield Pharmaceuticals
President, and EVP of R&D, of Xilio Therapeutics
President and Chief Executive Officer, Genocea Biosciences, Inc.
Vice President, Discovery Biotherapeutics, Bristol Myers Squibb
Chief Legal Officer of Bluebird Bio
Director at Broadview Ventures
Vice President, Neuroscience Research at Amgen
President and CEO at Organogenesis Inc.
Principal, RMG Associates
Vice President of Discovery, AbbVie
President of Pericor Science, Inc.
Chief Communications Officer, SVP Corporate Affairs & Citizenship, EQRx
Managing Director, Boehringer Ingelheim Venture Fund USA
EVP, Chief Regulatory Officer at Vertex
CEO at Stoke Therapeutics
Senior Vice President Value and Access at Biogen
Executive Chairmain, Aleta Biotherapeutics
Associate Vice President and Head, Boston Innovation Hub of BD&L Merck Research Laboratories
Head of Global Oncology Patient Value, Policy and Access at Takeda Oncology
Advisor at Red Sky Partners; Founder and Managing Director at Accendo
CEO of Alexandria Real Estate Equities, Inc.
President & CEO of Rhythm Therapeutics
Executive Vice President, R&D and Chief Medical Officer at Sarepta
Partner at McDermott, Quilty & Miller LLP
CEO & Chair at Infinity Pharmaceuticals
President & CEO, Arranta Bio
Vice President & Head, East Coast Innovation Center
Vice President, Government Relations and Public Affairs at Sunovion
President of Minerva Neurosciences
Executive Vice President and Head of Sanofi Genzyme
VP and ERDI Head at Pfizer
Vice-President, Scientific Partnering and Alliances and Site Head, R&D Boston at AstraZeneca
Vice President, U.S. Government Affairs, Alexion Pharmaceuticals, Inc.
President, EMD Serono, Global Head of the Innovative Medicine Franchises, Member of the Healthcare Executive Committee, Merck KGaA, Darmstadt, Germany
Chief Regulatory Officer of Flexion Therapeutics